Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,084 | 247 | 99.7% |
| Education | $13.89 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $559.55 | 39 | $0 (2024) |
| ABBVIE INC. | $489.81 | 28 | $0 (2024) |
| Novo Nordisk Inc | $457.53 | 30 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $294.14 | 13 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $224.51 | 14 | $0 (2019) |
| PFIZER INC. | $216.47 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $205.29 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $170.50 | 10 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $165.58 | 13 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $160.87 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,348 | 74 | Lilly USA, LLC ($234.59) |
| 2023 | $1,434 | 84 | AbbVie Inc. ($265.50) |
| 2022 | $11.80 | 1 | Antares Pharma, Inc. ($11.80) |
| 2020 | $175.73 | 12 | Novo Nordisk Inc ($54.57) |
| 2019 | $662.19 | 42 | SANOFI-AVENTIS U.S. LLC ($166.30) |
| 2018 | $452.22 | 34 | Novo Nordisk Inc ($79.17) |
| 2017 | $13.89 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13.89) |
All Payment Transactions
248 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: PAIN | ||||||
| 11/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Insomnia | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Cardio-renal | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Oncology | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Cardio-renal | ||||||
| 10/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: PAIN | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Insomnia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 100 | 209 | $29,339 | $14,240 |
| 2022 | 9 | 634 | 755 | $96,105 | $45,566 |
| 2021 | 9 | 579 | 732 | $92,510 | $45,461 |
| 2020 | 13 | 569 | 701 | $96,980 | $39,739 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 94 | $17,390 | $9,503 | 54.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 41 | $5,945 | $2,815 | 47.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $5,500 | $1,428 | 26.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 63 | $504.00 | $493.92 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 173 | $25,950 | $14,025 | 54.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 91 | 91 | $27,300 | $12,078 | 44.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 96 | 96 | $12,000 | $7,769 | 64.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 116 | $14,500 | $5,772 | 39.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 39 | 39 | $4,875 | $2,732 | 56.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 86 | 86 | $6,450 | $1,598 | 24.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 42 | $1,470 | $1,256 | 85.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 19 | $1,235 | $174.30 | 14.1% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 93 | 93 | $2,325 | $161.87 | 7.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 112 | 199 | $29,850 | $16,813 | 56.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 69 | 69 | $20,700 | $9,403 | 45.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 94 | 145 | $18,125 | $8,126 | 44.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 66 | 66 | $8,250 | $5,525 | 67.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 46 | 46 | $5,750 | $3,056 | 53.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 60 | 60 | $4,500 | $1,132 | 25.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 56 | 58 | $2,030 | $1,002 | 49.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 14 | 27 | $1,755 | $278.40 | 15.9% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2021 | 62 | 62 | $1,550 | $126.54 | 8.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 117 | 189 | $28,350 | $12,626 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 72 | 72 | $21,600 | $8,557 | 39.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 105 | 158 | $19,750 | $6,269 | 31.7% |
About Dr. Michelle Bauer, DO
Dr. Michelle Bauer, DO is a Family Medicine healthcare provider based in Trenton, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750463071.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Bauer, DO has received a total of $4,098 in payments from pharmaceutical and medical device companies, with $1,348 received in 2024. These payments were reported across 248 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,084).
As a Medicare-enrolled provider, Bauer has provided services to 1,882 Medicare beneficiaries, totaling 2,397 services with total Medicare billing of $145,007. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Trenton, MI
- Active Since 10/19/2006
- Last Updated 02/22/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1750463071
Products in Payments
- VRAYLAR (Drug) $379.75
- QUVIVIQ (Drug) $294.14
- Rybelsus (Drug) $203.69
- MOUNJARO (Drug) $171.63
- VOQUEZNA (Drug) $160.87
- Ozempic (Drug) $157.57
- JARDIANCE (Drug) $156.89
- TOUJEO (Drug) $141.02
- XIFAXAN (Drug) $132.78
- XARELTO (Drug) $129.17
- FARXIGA (Drug) $126.90
- EMGALITY (Drug) $113.99
- Cologuard Collection Kit (Device) $97.57
- NURTEC ODT (Drug) $84.46
- SOLIQUA 100/33 (Drug) $83.49
- TRULICITY (Drug) $82.58
- Auvelity (Drug) $82.15
- SPIRIVA RESPIMAT (Drug) $79.08
- TRINTELLIX (Drug) $71.43
- BREZTRI (Drug) $65.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Trenton
Dr. Michael Ducato, Md, MD
Family Medicine — Payments: $27,288
Jennifer Fretz, D.o, D.O
Family Medicine — Payments: $16,214
Dr. James Williams, Md, MD
Family Medicine — Payments: $14,581
Dr. Cresandra Corbin, M.d, M.D
Family Medicine — Payments: $7,729
Paul Walker, D.o, D.O
Family Medicine — Payments: $2,917
Dr. Jeffrey Rednor, D.o, D.O
Family Medicine — Payments: $2,453